Dianabiotech
2 known investors
DIANA Biotechnologies develops PCR and RT-PCR reagents, custom oligonucleotide synthesis, monoclonal antibodies, ultrasensitive sepsis diagnostics, and kinase inhibitor profiling services for diagnostic and academic laboratories. The company relies on its PCR expertise and proprietary DIANA technology, with products available across 18 European countries.
Founders & leadership
MD
Martin DienstbierCo-CEO
Investors · 2
Frequently asked questions
- What does Dianabiotech do?
- DIANA Biotechnologies develops PCR and RT-PCR reagents, custom oligonucleotide synthesis, monoclonal antibodies, ultrasensitive sepsis diagnostics, and kinase inhibitor profiling services for diagnostic and academic laboratories. The company relies on its PCR expertise and proprietary DIANA technology, with products available across 18 European countries.
- Who are Dianabiotech's investors?
- Dianabiotech's investors include B3 Holding, Biotech Investments S.R.O.